Perspective Therapeutics (CATX) Payables (2011 - 2026)
Perspective Therapeutics (CATX) posted Payables of $26.5 million for Q1 2026, up 29.05% sequentially from $20.6 million in Q4 2025, and up 202.05% YoY from $8.8 million in Q1 2025.
Perspective Therapeutics (CATX) Payables (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Payables for 16 years, with the latest figure at $26.5 million in Q1 2026.
- Quarterly Payables rose 202.05% year-over-year to $26.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.5 million (up 202.05% YoY) and the FY2025 annual result came in at $20.6 million, up 97.85% from the prior year.
- Payables grew to $26.5 million in Q1 2026 per CATX's latest filing, from $20.6 million in the prior quarter.
- Over five years, Payables peaked at $26.5 million in Q1 2026 and troughed at $769000.0 in Q1 2022.
- A 5-year average of $8.6 million and a median of $6.2 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2025: Payables surged 458.47% in 2024, then slumped 39.61% in 2025.
- Over 5 years, Payables stood at $1.5 million in 2022, then surged by 351.52% to $7.0 million in 2023, then surged by 49.4% to $10.4 million in 2024, then soared by 97.85% to $20.6 million in 2025, then increased by 29.05% to $26.5 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $26.5 million, $20.6 million, and $13.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 5.89 Bn |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 2.00 Bn |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 2.51 Bn |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 587.50 Mn |
| 10 | Perspective Therapeutics | 387.89 Mn | 387.89 Mn | - | 29.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.48 Mn |
| Mar 31, 2026 | 26.54 Mn |
| Dec 31, 2025 | 20.57 Mn |
| Sep 30, 2025 | 13.20 Mn |
| Jun 30, 2025 | 7.10 Mn |
| Mar 31, 2025 | 8.79 Mn |
| Dec 31, 2024 | 10.40 Mn |
| Sep 30, 2024 | 21.86 Mn |
| Jun 30, 2024 | 6.18 Mn |
| Mar 31, 2024 | 6.08 Mn |
| Dec 31, 2023 | 6.96 Mn |
| Sep 30, 2023 | 3.92 Mn |
| Jun 30, 2023 | 4.98 Mn |
| Mar 31, 2023 | 3.99 Mn |
| Dec 31, 2022 | 1.54 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 966,000.00 |
| Mar 31, 2022 | 769,000.00 |
| Dec 31, 2021 | 847,000.00 |
| Sep 30, 2021 | 768,000.00 |